. "Appendix H: Anticipating Unintended Consequences of Vaccine-Like Immunotherapies for Addictive Drug Use." New Treatments for Addiction: Behavioral, Ethical, Legal, and Social Questions. Washington, DC: The National Academies Press, 2004.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
New Treatments for Addiction: Behavioral, Ethical, Legal, and Social Questions
Vaughan, D. (1996). The Challenger launch decision: Risky technology, culture, and deviance at NASA. Chicago: University of Chicago Press.
Viscusi, W.K. (1992). Fatal tradeoffs: Public and private responsibilities for risk. Oxford, England: Oxford University Press.
Viswesvaran, C., and Schmidt, F.L. (1992). A meta-analytic comparison of the effectiveness of smoking cessation methods. Journal of Applied Psychology,77, 554-561.
Vuchinich, R., and Heather, N. (Eds.). (2003). Choice, behavioural economics and addiction. Oxford, England: Elsevier Science.
White, J.M., Winn, K.I., and Young, W. (1998). Predictors of attrition from an outpatient chemical dependency program. Substance Abuse,19, 49-59.
Wilde, G.J.S. (1982). The theory of risk homeostasis: Implications for safety and health. Risk Analysis,2, 209-255.
Williams, J., Pacula, R.L., Chaloupka, F.J., and Wechsler, H. (2001). Alcohol and marijuana use among college students: Economic complements or substitutes? Cambridge, MA: National Bureau of Economic Research.
World Health Organization. (2001). Advancing knowledge on regulating tobacco products. Geneva: World Health Organization.
Zito, J.M., Craig, T.J., and Wanderling, J. (1991). New York under the Rivers decision: An epidemiologic study of drug treatment refusal. American Journal of Psychiatry,148(7), 904-909.